Mario-Demian Mutuleanu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 17

Top Topics

Metastatic Breast Cancer

Positron Emission Tomography

Ejection Fraction

Top Venues

Diagnostics (Basel, Switzerland)

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Mirela Gherghe, Alexandra Maria Lazar, Maria-Carla Sterea, Paula Monica Spiridon, Natalia Motas, Laurentia Nicoleta Gales, Daniel Coriu, Sorina Nicoleta Bădeliţă, Mario-Demian Mutuleanu
Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging. Journal of cardiovascular development and disease 10 (6) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Laurentiu Simion, Ionela-Nicoleta Irimescu, Maria-Carla Sterea, Mario-Demian Mutuleanu, Rodica Maricela Anghel
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Laurentiu Simion, Ionela-Nicoleta Irimescu, Maria-Carla Sterea, Mario-Demian Mutuleanu, Rodica Maricela Anghel
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Mario-Demian Mutuleanu, Diana Loreta Paun, Alexandra Maria Lazar, Cristina Petroiu, Oana Gabriela Trifanescu, Rodica Maricela Anghel, Mirela Gherghe
Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation-A Review of the Literature. Diagnostics (Basel, Switzerland) 13 (18) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Laurentiu Simion, Ionela-Nicoleta Irimescu, Maria-Carla Sterea, Mario-Demian Mutuleanu, Rodica Maricela Anghel
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Maria-Carla Sterea, Paula Monica Spiridon, Natalia Motas, Laurentia Nicoleta Gales, Daniel Coriu, Sorina Nicoleta Bădeliţă, Mario-Demian Mutuleanu
Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging. Journal of cardiovascular development and disease 10 (6) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Laurentiu Simion, Ionela-Nicoleta Irimescu, Maria-Carla Sterea, Mario-Demian Mutuleanu, Rodica Maricela Anghel
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Maria-Carla Sterea, Paula Monica Spiridon, Natalia Motas, Laurentia Nicoleta Gales, Daniel Coriu, Sorina Nicoleta Bădeliţă, Mario-Demian Mutuleanu
Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging. Journal of cardiovascular development and disease 10 (6) (2023)
Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Maria Lazar, Radu Valeriu Toma, Oana Gabriela Trifanescu, Rodica Maricela Anghel
Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT. Cancers 15 (3) (2023)
Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Maria Lazar, Radu Valeriu Toma, Oana Gabriela Trifanescu, Rodica Maricela Anghel
Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT. Cancers 15 (3) (2023)
Alexandra Maria Lazar, Mario-Demian Mutuleanu, Paula Monica Spiridon, Cristian Ioan Bordea, Tatiana Lucia Suta, Alexandru Blidaru, Mirela Gherghe
Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy-A Single-Tertiary Centre Experience and Review of the Literature. Diagnostics (Basel, Switzerland) 13 (18) (2023)
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Cristian Ioan Bordea, Sinziana-Octavia Ionescu, Raluca Ioana Mihaila, Cristina Petroiu, Adina Elena Stanciu
Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact? Cancers 15 (1) (2022)
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Cristian Ioan Bordea, Sinziana-Octavia Ionescu, Raluca Ioana Mihaila, Cristina Petroiu, Adina Elena Stanciu
Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact? Cancers 15 (1) (2022)
Mirela Gherghe, Alexandra Maria Lazar, Adina Elena Stanciu, Mario-Demian Mutuleanu, Maria-Carla Sterea, Cristina Petroiu, Laurentia Nicoleta Gales
The New Radiolabeled Peptide 99m TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers 14 (11) (2022)
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Cristian Ioan Bordea, Sinziana-Octavia Ionescu, Raluca Ioana Mihaila, Cristina Petroiu, Adina Elena Stanciu
Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact? Cancers 15 (1) (2022)
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Adina Elena Stanciu, Sorina Carmen Martin
Radiomics Analysis of [ 18 F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients' Clinical Management? A Systematic Review from the Literature. Diagnostics (Basel, Switzerland) 12 (2) (2022)
Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Maria Lazar, Xenia Bacinschi, Rodica Maricela Anghel
Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients-The Clinical Significance. Cancers 14 (2) (2022)